November 2019 prioritisation decisions

Document first published:
Page updated:
Publication type:

Twice a year, NHS England makes decisions on which new specialised treatments should be routinely commissioned. The decisions are taken by the NHS England Board based on recommendations from the Clinical Priorities Advisory Group (CPAG) which is made up of doctors, health experts, and patient representatives.

Treatments are grouped into five levels of priority, with those that have the highest relative clinical benefit for patients and the lowest relative cost classified as level one, and treatments with the lowest relative clinical benefit and highest relative cost are classified as level five.

The ranking of treatments considered in the November 2019 prioritisation round is set out in this document.